Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pluri-Franchise
Haifa, Haifa, Israel
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Pluri develops proprietary large-scale GMP-compliant platforms for the expansion of human cells—primarily for regenerative medicine but also food-tech and agricultural biotech. Its core technology enables mass production of high-quality cells with batch-to-batch consistency. The company has supported late-stage clinical trials in multiple jurisdictions but does not have an approved therapeutic product as of mid–2025. It recently expanded into contract development and manufacturing services for advanced therapies including stem cells, iPSCs, exosomes, gene-modified cells such as CAR-Ts.
- Therapeutic areas
- OtherCardiovascularImmunologyHematology
- Modalities
- Cell therapyInduced pluripotent stem cell derived therapyExosome-based therapyGene modified cell therapies, including CAR-T cell therapyMesenchymal Stem CellsiPSCsExtracellular Vesicles
- Industry
- Biotech
02
Partnerships
Multiple undisclosed partnerships leveraging its platform technology across pharma/biotech sectors. Recent focus on expanding strategic collaborations through its CDMO business line.
Beyond the preview
Go deeper on Pluri-Franchise.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pluri-Franchise.